The EU Cancer Mission & Research
European Cancer Organisation
177 videos
Welcome! From here you can access useful information and resources from the European Cancer Organisation, its European Cancer Summit 2022, Member Societies, Patient Advocacy Groups and Community...
Read More
Welcome! From here you can access useful information and resources from the European Cancer Organisation, its European Cancer Summit 2022, Member Societies, Patient Advocacy Groups and Community 365.
European Cancer Organisation
Speakers
Christine Chomienne is Vice Chair of the EU Cancer Mission & Professor of Cellular Biology at the Université de...
Christine Chomienne is Vice Chair of the EU Cancer Mission & Professor of Cellular Biology at the Université de Paris, France. She is currently Vice-Chair of the Mission Board Cancer at the European Commission. She was Director of Research and Innovation at the French National Cancer Institute (INCa) and Director of the Cancer Institute of France Research Organisations (Inserm & AVIESAN). She is past president of the European Hematology Association. She qualified in medicine at the Université Paris Diderot and received certification for specialized training in Hematology in 1983. She obtained her PhD in 1989. Dr. Chomienne has served on many scientific and clinical committees in France and Europe in Leukemia, Immunology, Oncology and Stem Cell Research. She was head of the Cell Biology Department at the Hôpital Saint Louis, Paris and Director of the University Inserm Research Laboratory at the Institut Universitaire d’Hématologie for the last 25 years. She is committed to education nationally and coordinator of different Courses and Masters at the University Paris Diderot. She established the Institute of PhD Schools at the University Paris Diderot (23 PhD of all disciplines) and coordinated an ITN Marie Curie FP7 on Cancer Stem Cells. She has recently been involved in patient/parent participation in cancer research and in communication education on personalized medecine. Dr. Chomienne is author of more than 270 peer-reviewed publications and has received several scientific (Academia of Science) and French governmental awards (Legions of Honour).
Elisabete Weiderpass, MD, MSc, PhD, is a Brazilian cancer researcher who is a naturalized Swedish and Finnish...
Elisabete Weiderpass, MD, MSc, PhD, is a Brazilian cancer researcher who is a naturalized Swedish and Finnish citizen. She is an expert in cancer epidemiology and cancer prevention. In January 2019, Dr Weiderpass took office as elected Director of the International Agency for Research on Cancer (IARC). Dr Weiderpass previously served as Head of the Department of Research at the Cancer Registry of Norway, and of the Genetic Epidemiology Group at the Folkhälsan Research Center in Finland. She was a Professor of Medical Epidemiology at the Karolinska Institutet in Stockholm, Sweden, and a Professor of Cancer Epidemiology at the Arctic University of Norway. She held Adjunct Professorship positions in Cancer Epidemiology in Brazil, China, and the Islamic Republic of Iran, and is a Visiting Professor in Kuwait. Dr Weiderpass has authored over 900 scientific publications in peer-reviewed international journals.
Jan Geissler is EU Cancer Mission Assembly Member and Member of the European Cancer Organisation's Patient Advisory...
Jan Geissler is EU Cancer Mission Assembly Member and Member of the European Cancer Organisation's Patient Advisory Committee, he is the founder and CEO of Patvocates, a think tank, consultancy and social enterprise on patient advocacy, health policy and patient engagement in research. He was the Director of the European Patients Academy (EUPATI) from 2012-2017 and still leads the German EUPATI platform. Jan is a work package leader of the IMI2-funded EU project HARMONY on big data for better outcomes in hematology. A leukemia survivor since 2001, Jan co-founded the patient organisations LeukaNET/Leukaemie-Online.de in 2002, the European Cancer Patient Coalition in 2003, the CML Advocates Network in 2007, the Leukemia Patient Advocates Foundation in 2011, WECAN in 2015 and the Acute Leukemia Advocates Network in 2016. Jan represents patients on a number of advisory boards and committees, e.g. European Cancer Organisation, EHA, ISPOR, Berlin Institute of Health, EuroBloodNET, International CML Foundation, the EU Cancer Mission Assembly, the German National Decade Against Cancer and the Ethics Committee of the Bavarian Chamber of Physicians.
Kees Roks is the Head of the European Oncology Business at Novartis Pharma, Switzerland. Since November 2018 he is...
Kees Roks is the Head of the European Oncology Business at Novartis Pharma, Switzerland. Since November 2018 he is responsible for leading over 2000 dedicated associates in 51 countries on the journey to reimagine medicines. His Novartis career started in 1985 in the Netherlands. Since then he has held various roles of increasing responsibility in several international markets and cultures from Europe to Latin America and even as far away as Japan. Each move has given him a greater perspective on why access, affordability, and accessibility to care are now more critical than ever. Beyond his professional career, he is a member of the EFPIA Patient Access Committee. He is part of the Assembly for the EU Cancer Mission and is a member of the Scientific Advisory Board for the Open Research Europe initiative, both for the European Commission. Kees studied Medical Microbiology and holds a degree in Business Administration from the University of Eindhoven, Netherlands.
Mariya Gabriel is the European Commissioner for Innovation, Research, Culture, Education, Youth and Sport. Under her...
Mariya Gabriel is the European Commissioner for Innovation, Research, Culture, Education, Youth and Sport. Under her leadership, the new Horizon Europe, Erasmus+, and the cultural strand of Creative Europe programmes (2021-2027) will be defined and implemented. Her main priorities are excellence in research, innovation and education (ERA, EEA, EIA); tackling the R&I divide in Europe; Europe as a leader in strategic innovation areas through the digital and green transition, with a particular attention for young people and regions. “No one left behind” and “Think out of the box” are her mottos. Between 2017 and 2019, Mariya Gabriel was European Commissioner for Digital Economy and Society. She was elected as Member of the European Parliament (MEP) in 2009, 2014 and 2019. Mariya Gabriel is First Vice-President of the European People's Party (EPP), and, since 2012, Vice-President of EPP Women. Commissioner Gabriel is a board member of the United Nations youth programme Generation Unlimited (GenU). She has been ranked among the 50 most influential women in Europe in the field of cybersecurity by the leading European cybersecurity magazine SC Media UK (2019). Mariya Gabriel is also known for her involvement in the fight for gender equality. Among others, she received the prestigious Italian prize “Golden Apple” for highest achievements for women.
Immediate Past-President, European Cancer Organisation (ECO) Matti Aapro is member of the Board of Directors of the...
Immediate Past-President, European Cancer Organisation (ECO) Matti Aapro is member of the Board of Directors of the Genolier Cancer Center, Genolier, Switzerland and Immediate Past-President of the European Cancer Organisation. He received his medical degree from the Faculty of Medicine, University of Geneva, Switzerland and was a fellow at the Arizona Cancer Center in Tucson, Arizona, USA. He was the founding chair of the Medical and Radiation Therapy Department at the European Institute of Oncology in Milan. Dr. Aapro is presently Executive Board member of the European School of Oncology (ESO). He leads the Sharing Progress in Cancer Care (SPCC) not-for-profit association. He serves the International Society for Geriatric Oncology (SIOG) as Executive Board Member. He is past-President of the Multinational Association for Supportive Care in Cancer (MASCC). He is President of Honour of the French-speaking Society for Supportive Care (AFSOS), as well as Advisor to the Japanese Association for Supportive Care in Cancer (JASCC). He has been member of the Board of the European Organization for Research and Treatment of Cancer (EORTC) and of the Board of the European Society of Medical Oncology (ESMO). Dr. Aapro chaired the scientific and organizing committees of UICC’s (International Union against Cancer) World Cancer Congress of 2008 in Geneva, and 2010 in Shenzhen (China). He is a member of the ESMO Faculty and chaired the ESMO 2018 Supportive/Palliative Care track. Dr. Aapro is Honorary Editor of Critical Reviews in Oncology/Hematology, and editor of the Journal of Cancer Policy as well as Associate Editor for the geriatric section of the Oncologist. He is also founding editor of the Journal of Geriatric Oncology. He is past Associate Editor for Annals of Oncology, continuing on its editorial board, and member of several other editorial boards including CancerWorld. He has authored more than 350 publications and his major interests are new drug development, breast cancer, cancer in the elderly, and supportive care. Dr. Aapro is Doctor Honoris Causa of the University of Tampere (2013) and Honorary Member of the Russian Society for Clinical Oncology (RUSSCO)(2016). He has received the 2010 Acta Oncologica Award, the 2012 ASCO B.J. Kennedy prize and the MASCC Distinguished Services Award (2016).
Walter Ricciardi is Chair of the EU Cancer Mission. Professor of Hygiene and Public Health at Università Cattolica...
Walter Ricciardi is Chair of the EU Cancer Mission. Professor of Hygiene and Public Health at Università Cattolica del Sacro Cuore, Rome. Scientific Advisor to the Italian Minister of Health for the coronavirus pandemia. Scientific Director of Istituti Clinici Scientifici Maugeri. President of the World Federation of Public Health Associations (WFPHA). President of Mission Board for Cancer of European Commission. Coordinator of the Scientific Advisory Board of Human Technopole Foundation. Principal Investigator of EC Grant “TO REACH” the first health services and health systems research programme funded by European Commission (since 2016). Italian Representative in the Executive Board of World Health Organisation (November 2017-May 2020). Head of Department of Woman and Child Health and Public Health of Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Università Cattolica del Sacro Cuore (from January to December 2019). Former President of Istituto Superiore di Sanità (Italian National Institute of Health) (2015-2018) and its Commissioner from July 2014 to July 2015. Member of the Expert Panel on effective ways of investing in Health (European Commission, DG – SANTE) for two three-year mandates (2013-2019). President elect of European Public Health Association (EUPHA) (2010-2014); since 2014 he is Past President of EUPHA. Member of the III Sezione del Consiglio Superiore di Sanità, Ministry of Health (December 2009 – July 2010) and its President (December 2010 – July 2014) He manages several undergraduate and postgraduate teaching activities. Editor of European Journal of Public Health, of Oxford Handbook of Public Health Practice and Founding Editor of Italian Journal of Public Health and of Epidemiology, Biostatistics and Public Health. “Laurea Honoris Causa” at Thomas Jefferson University, Philadelphia, USA (2019). Appointed “Commendatore” of the Italian Republic by Decree of the President of the Republic 02 June 2017.
Start a conversation